News & Media

Events
BIO Europe 2018

Read more
Events
Interim Report January - September 2018

Read more
Events
Nordic Life Sciences Day

Read more
Events
Interim Report January-June 2018

Q2 Conference call Wednesday, 25 July 2018, at 14.00 (CET). Phone numbers for participants from: Sweden + 46 8 566 426...

Read more
Press release
Medivir announces positive top-line results from the MIV-711 osteoarthritis phase IIa extension study

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced positive top-line results from the MIV-711 phase IIa extension study (MIV-711-202)....

Read more
Press release
Continued discussions with FDA on proposed remetinostat phase III design results in delay in planned start of study

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions...

Read more
Press release
Phase I/II study design of birinapant in combination with Keytruda® to be presented on June 4 at the ASCO Annual Meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that the design of the ongoing phase I/II study of birinapant...

Read more
Press release
Additional remetinostat phase II data will be presented at the International Investigative Dermatology meeting on May 18 and 19

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that additional data from the phase II study of remetinostat in...

Read more
Press release
Resolutions at the Annual General Meeting in Medivir on 3 May 2018

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing directorThe...

Read more
Press release
Number of shares and votes in Medivir

Stockholm, Sweden - Medivir AB (”Medivir” or the ”Company”) (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes...

Read more
Press release
MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2018

Significant events during the quarter The holders of series A shares have notified the Company that they will convert all their...

Read more
Blog
The transformation of Medivir

A lot of work has been spent on our science and the continued development of our broad pipeline – including both...

Read more